Epigenetics of neuromuscular disorders

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Neuromuscular disorders encompass a diverse range of conditions impacting the neuromuscular system.
• Understanding the underlying molecular mechanisms is crucial for developing effective treatments.

Purpose of the Study:

• To review significant epigenetic findings in motor neuron diseases and hereditary muscular dystrophies.
• To explore the potential of epigenetic biomarkers and therapies in clinical applications.

Main Methods:

• Review of current literature on epigenetic alterations in neuromuscular disorders.
• Analysis of DNA methylation patterns and non-coding RNA investigations.
• Examination of preclinical studies involving epigenetic drugs in animal and cell models.

Main Results:

• DNA methylation changes are evident in both hereditary and sporadic forms of neuromuscular disorders.
• Epigenetic drug development shows potential for reduced toxicity and increased selectivity.
• Non-coding RNAs are emerging as valuable biomarkers and therapeutic targets.

Conclusions:

• Epigenetic biomarkers offer significant potential for enhancing diagnostic and prognostic accuracy in neuromuscular disorders.
• Targeted epigenetic therapies hold promise for future clinical interventions.
• Further research into epigenetic mechanisms can lead to novel treatment strategies.